Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Akers Biosciences Inc.
AKER
$
3.34
4%
Tue February 23rd, 2021
18:25
Akers Biosciences' Proposed Partner MyMD's Lead Candidate Inhibits Fibrotic Diseases-Associated Biomarkers
Benzinga
Wed November 18th, 2020
21:51
Press Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER
PR Newswire
Tue November 17th, 2020
20:55
Press Releases
RM LAW Announces Investigation of Akers Biosciences, Inc.
PR Newswire
Fri November 13th, 2020
02:38
Press Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Akers Biosciences, Inc.
PR Newswire
Thu November 12th, 2020
20:21
Press Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Akers Biosciences, Inc.
PR Newswire
Sat August 29th, 2020
18:01
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Digest
Wall Street Breakfast: What Moved Markets
Seeking Alpha
